Stone Pharmaceuticals Group (01093.HK) has received a milestone payment of $10 million from AstraZeneca under the strategic research and development collaboration agreement.

According to a report from Zhifeng Finance APP, Shang Pharmaceutical Group (01093.HK) announced that it has signed a strategic research and development cooperation agreement (the Agreement) with AstraZeneca to discover and develop new oral small molecule candidate drugs. Unless otherwise defined, the terms used in this announcement shall have the same meanings as defined in the announcement.